Mazanet Rosemary

Oncternal Therapeutics, Inc. · Director

Mazanet Rosemary is listed in filings as Director at Oncternal Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 24, 2024, including 1 public disclosure. Recent filings connect the profile to Oncternal Therapeutics, Inc. (ONCT). The current snapshot covers public activity from Jun 24, 2024. Reported amounts are shown as $17.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.